Notice on Convening the 2nd Extraordinary General Meeting in 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 2nd Extraordinary General Meeting in 2025
Filed with SSE · · 8 pages · Chinese
Release
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. on 6ix
Earlier from Sunshine Guojian Pharmaceutical (Shanghai)
- Report for Q1 2025
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trials
- Announcement on Resolutions of the 3rd Meeting of the 5th Board of Supervisors
- Announcement on Convening the 1st Extraordinary General Meeting in 2025
Later from Sunshine Guojian Pharmaceutical (Shanghai)
- Announcement on Abnormal Fluctuations and Serious Abnormal Fluctuations in Stock Trading
- Announcement on Using Surplus Funds from Some Projects to Temporarily Supplement Current Capital and Adjusting the Amount of Raised Funds to be Invested in Some Investment Projects Financed by Raised Funds
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Resolution of the 6th Meeting of the 5th Board of Supervisors
Follow Sunshine Guojian Pharmaceutical (Shanghai) into a list and get an email when it puts out news.
Follow Sunshine Guojian Pharmaceutical (Shanghai)